‘Profit over death’: millions of American diabetics struggle to afford insulin | Society | The Guardian

The Trump administration has touted several executive orders issued in May and July 2020 aimed at cutting the cost of insulin in the US. But diabetics and activists for affordable insulin argue the orders have accomplished little in reducing exorbitant costs as diabetics continue to struggle to afford the insulin they need to live.

According to a recent report published by the Rand Corporation, insulin prices in the US remain five to 10 times higher than the prices of the same insulin in other countries.

Source: ‘Profit over death’: millions of American diabetics struggle to afford insulin | Society | The Guardian